(redirected from Graft rejection)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.
Related to Graft rejection: Graft versus host disease


A colloquial term referring to the unlawful acquisition of public money through questionable and improper transactions with public officials.

Graft is the personal gain or advantage earned by an individual at the expense of others as a result of the exploitation of the singular status of, or an influential relationship with, another who has a position of public trust or confidence. The advantage or gain is accrued without any exchange of legitimate compensatory services.

Behavior that leads to graft includes Bribery and dishonest dealings in the performance of public or official acts. Graft usually implies the existence of theft, corruption, Fraud, and the lack of integrity that is expected in any transaction involving a public official.


noun blackmail, bribery, corruption, fraudulent income, hush money, illegal profit, illicit profit, illicit revenue, inserere, kickback, money illegally accuired, political corruption, profiteering, property illegally acquired, unjust acquisition, unlawful gain
Associated concepts: bribery, corruption, official misconduct
See also: bribe, connect, corruption, crime, gratuity, hush money, improbity, spoils

GRAFT. A figurative term in chancery practice, to designate the right of a mortgagee in premises, to which the mortgagor at the time of making the mortgage had an imperfect title, but who afterwards obtained a good title. In this case the new mortgage is considered a graft into the old stock, and, as arising in consideration of the former title. 1 Ball & Beat. 46; Id. 40; Id. 57; 1 Pow. on Mortg. 190. See 9 Mass. 34. The same principle has obtained by legislative enactment in Louisiana. If a person contracting an obligation towards another, says the Civil Code, art. 2371, grants a mortgage on property of which he is not then the owner, this mortgage shall be valid, if the debtor should ever acquire the ownership of, the property, by whatever right.

References in periodicals archive ?
Current transplant technology requires lifelong treatment with powerful immunosuppressant drugs to prevent graft rejection.
Neovascularisation in this part of the eye is a major risk factor in corneal graft rejection, the most common transplantation procedure that saves the sight of approximately 46,000 people worldwide each year.
We have moved GS-101 through clinical evaluation and are now conducting an international phase III trial for the prevention of pathologic corneal neovascularisation, a major risk factor in corneal graft rejection, the most common transplantation procedure that saves the sight of approximately 46,000 people worldwide each year.
One year and longer after transplant, there were 2 cases of graft rejection in the 13 remaining study patients compared with 20 cases in the remaining 22 controls.
Another major issue addressed in the company's primate studies is that of the dosage of immune suppression treatment needed for the prevention of graft rejection.
Twenty years ago, our primary goal was getting transplant recipients through complex transplantation surgery and avoiding graft rejection.
For posttransplant immunosuppression, the investigators administered tacrolimus at markedly reduced levels and continued to taper the dose even further, aiming for the minimum amount of immunosuppression sufficient to avoid graft rejection.
Current methods are not sensitive enough to detect loss of islet cell function until the latter stages of graft rejection.
Sc28AT may block graft rejection as well as the initiation and development of autoimmune diseases, while keeping the body's natural regulatory mechanisms.
According to an analysis of 8 trials, the addition of anti-interleukin-2 receptor antibodies to patients' therapy cut the incidence of acute graft rejection by 49% in the six months after renal transplantation.
The compounds have been developed following the discovery that CO, like nitric oxide, is a naturally occurring chemical messenger that, in physiological doses, has anti-inflammatory, hypotensive and anti-apoptotic properties and can suppress graft rejection and protect tissues from ischemic damage.
Doctors have thought the main reason transplant patients develop KS is that they are already "silently" infected with HHV-8, which progresses to cancer when the patients take immunosuppressant drugs to prevent graft rejection.